Veterinary Medicines

Rismavac Comp. Vet. koncentrat og solvens til injektionsvæske, suspension

Authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Download as PDF

Product identification

Medicine name:
Rismavac Comp. Vet. koncentrat og solvens til injektionsvæske, suspension
Rismavac Comp. Vet. koncentrat og solvens til injektionsvæske, suspension
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Target species:
  • Poultry
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    1000.00
    plaque forming unit
    /
    1.00
    Dose
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
    1000.00
    plaque forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 19466
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 2/12/2025
Download